Collecting Information From Patients Enrolled in the Breast Specialized Program of Research Excellence
NCT ID: NCT01004562
Last Updated: 2015-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1025 participants
OBSERVATIONAL
2007-08-31
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This study is collecting information from patients enrolled in the Breast Specialized Program of Research Excellence.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer
NCT00898131
Blood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and Sisters
NCT00445562
Understanding Value in Metastatic Breast Cancer
NCT03257917
A Biological Sample Collection Protocol of Women With and Without Breast Cancer
NCT00472589
Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT01101425
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Provide a database for administrative and biostatistical support for the Breast Specialized Program of Research Excellence.
OUTLINE: Data is collected from patients for future research studies.
PROJECTED ACCRUAL: A total of 535 patients will be accrued for this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
informational intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of breast cancer
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* Not specified
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yufeng Li, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UAB Comprehensive Cancer Center
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UAB-X010112005
Identifier Type: -
Identifier Source: secondary_id
CDR0000378061
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.